Healthmetryx Logo
Public Sector ROI Calculator

Quantify the value of respiratory intelligence infrastructure.

Estimate the economic impact of Healthmetryx deployments across nations, provinces, and municipal regions.

10–30%Modeled reduction in respiratory hospitalizations through early detection.
15–40%Modeled reduction in medical treatment costs for chronic respiratory conditions.
100%–0%Subsidy slider for fully or partially subsidized deployment models.

Public Sector Deployment ROI Calculator

Use the presets or enter your own jurisdiction data.

1. Jurisdiction profile

2. Population and deployment

3. Pricing and subsidy

4. Impact assumptions

GDP Impact Calculator

5. Macroeconomic assumptions

Estimated annual net public sector value$0
Monitored population0
Total gross economic impact$0
Total platform cost$0
Government subsidized cost$0
Participant / employer cost share$0
Public sector ROI on subsidy0.0x
Hospitalization savings$0
Treatment cost savings$0
Productivity improvement value$0
Claims / disability savings$0
Public health program efficiency$0
Annual GDP upside$0
10-year GDP upside$0
Combined annual value incl. GDP$0
35%Hospitalization
25%Treatment
20%Productivity
10%Claims
10%Program

Directional public-sector business case model. Not a guarantee of financial results.

Evidence Linked to Your ROI Outputs

Healthmetryx surfaces the most relevant public research sources for the largest value drivers. This supports procurement, budget justification, and policy review with transparent, evidence-based validation.

BrookingsMcKinsey Global InstituteWHOILOCDCIHMEOSHAAmerican Lung Association

Most relevant sources for this scenario

These cards show which public evidence areas are driving the business case for this deployment scenario.

GDP ImpactBrookings + McKinsey

Supports the macroeconomic value of health investment and GDP upside.

Review Brookings + McKinsey
HospitalizationsWHO + CDC

Supports early intervention and avoidable acute-care reduction.

Review WHO + CDC
Treatment CostsCOPD Cost Studies

Supports chronic disease cost, medication, and treatment burden categories.

Review COPD Cost Studies
Brookings Institution — Health & Economic Growth

Supports the macroeconomic case for national prevention programs and GDP expansion from improved health outcomes.

View Source →
McKinsey Global Institute — The Value of Better Health

Supports the health-investment return framework, including $2–$4 economic return per $1 invested and GDP upside by income group.

View Source →
U.S. Chamber Foundation — ROI of Health

Supports the broader economic-growth argument for health-system resilience and health investment.

View Source →

Procurement-ready, evidence-based validation aligned to globally recognized research.

The public links above validate the underlying economic categories, providing transparent alignment with global health, economic, and workforce research used by governments and institutions worldwide.

Request Public Sector Evidence Briefing →

Use case coverage across public sector deployments

Healthmetryx can be configured for national, regional, and municipal priorities.

National Programs

Respiratory health intelligence, pandemic early-warning, climate-health analytics, occupational exposure monitoring, and sovereign AI model development.

Province / State Programs

Regional hospital burden reduction, wildfire and pollution response, workforce exposure monitoring, public health targeting, and chronic disease management.

Municipal Programs

Smart city air quality, first responder readiness, neighborhood respiratory risk, school/facility air intelligence, and local public health outreach.

Build the public health infrastructure layer for respiratory intelligence.

Use this calculator in procurement, budget planning, and national preparedness discussions.

Request Public Sector Deployment Briefing →